TY  - JOUR

T1  - Cost-effectiveness of disease-modifying therapies in the management of multiple sclerosis for the Medicare population.

JO  - Value Health

PY  - 2009/01/09

AU  - Tappenden P

AU  - McCabe C

AU  - Chilcott J

AU  - Simpson E

AU  - Nixon R

AU  - Madan J

AU  - Fisk JD

AU  - Brown M

ED  - 

DO  - DOI: 10.1111/j.1524-4733.2008.00485.x

VL  - 12

IS  - 5

SP  - 657

EP  - 665

Y2  - 2024/10/22

ER  -